Metoprolol tartrate and succinate: from chemical structure to clinical effectiveness differences
.
Main Authors: | Yu. B. Belousov, M. V. Leonova, O. A. Maneshina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2007-06-01
|
Series: | Российский кардиологический журнал |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2158 |
Similar Items
-
CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: M. V. Soura
Published: (2016-01-01) -
Metoprolol tartrate. Сlinical use
by: A. A. Zateischikova
Published: (2015-12-01) -
The place of metoprolol tartrate in the treatment of cardiovascular diseases
by: N. V. Romanova, et al.
Published: (2016-12-01) -
Retard metoprolol tartrate: effectiveness and safety in patients with Functional Class II-III stable effort angina
by: A. A. Kuprina, et al.
Published: (2007-10-01) -
COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: J. V. Lukina, et al.
Published: (2015-12-01)